Saturday 17 October 2026
Export MCK’s income statement to Excel — free account
McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
1,006.92
8.28
+0.83%
Follow MCK
| Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 6 | 7 | 7 | 4 | 7 | 7 | 5 | 6 | 7 |
P/E ratio |
6.29 | 607.87 | 1,485.50 | 26.06 | 0.00 | 41.94 | 14.13 | 23.81 | 25.92 | 22.40 |
Altman Z-Score |
4.37 | 4.15 | 4.22 | 4.46 | 3.90 | 4.86 | 5.35 | 5.63 | 5.88 | 6.15 |
P/S ratio |
0.17 | 0.14 | 0.11 | 0.11 | 0.13 | 0.18 | 0.18 | 0.23 | 0.24 | 0.27 |
Altman Z″-Score (non-manufacturers) |
1.87 | 1.04 | 1.04 | 1.02 | 0.02 | 0.42 | 0.71 | 0.66 | 0.61 | 0.59 |
P/FCF ratio |
7.83 | 7.72 | 6.71 | 6.32 | 8.03 | 11.96 | 10.92 | 19.70 | 16.41 | 19.77 |
P/Operating CF |
22.83 | 9.62 | 5.99 | 5.25 | 9.29 | 16.15 | 15.11 | 17.23 | 11.07 | 31.27 |
Beneish M-Score |
(2.29) | (2.86) | (2.81) | (2.60) | (3.19) | (2.78) | (2.38) | (2.42) | (2.42) | (2.34) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 86 |
P/B ratio |
2.91 | 2.89 | 2.82 | 4.60 | 178.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.19 | 0.16 | 0.13 | 0.12 | 0.17 | 0.21 | 0.21 | 0.25 | 0.25 | 0.28 |
EV/EBITDA |
4.63 | 8.72 | 7.14 | 7.83 | 0.00 | 20.08 | 11.58 | 17.30 | 18.05 | 16.51 |
EV/Operating CF |
8.12 | 7.89 | 6.92 | 6.36 | 8.86 | 12.67 | 11.20 | 18.22 | 15.00 | 18.62 |
EV/FCF |
9.21 | 9.11 | 8.03 | 7.19 | 10.32 | 14.41 | 12.56 | 21.68 | 17.47 | 21.18 |
Quick Ratio |
0.59 | 0.56 | 0.56 | 0.56 | 0.58 | 0.46 | 0.50 | 0.50 | 0.51 | 0.48 |
Current Ratio |
1.04 | 1.01 | 1.02 | 0.99 | 1.03 | 0.95 | 0.92 | 0.92 | 0.90 | 0.85 |
Net Debt/EBITDA |
0.69 | 1.33 | 1.18 | 0.95 | (2.29) | 3.42 | 1.51 | 1.58 | 1.10 | 1.10 |
Debt/Assets |
14.02% | 13.05% | 12.73% | 12.06% | 23.40% | 20.69% | 19.61% | 17.41% | 14.98% | 14.11% |
Debt/Equity |
0.76 | 0.78 | 0.92 | 1.39 | 86.94 | (7.31) | (8.20) | (7.34) | (6.64) | (6.54) |
Asset Turnover |
3.38 | 3.43 | 3.57 | 3.82 | 3.77 | 4.11 | 4.41 | 4.76 | 5.04 | 5.12 |
Operating CF/Net income |
0.94 | 64.85 | 118.71 | 4.86 | (1.00) | 3.98 | 1.45 | 1.44 | 1.85 | 1.29 |
Capex/Depreciation |
(0.47) | (0.18) | (0.18) | (0.48) | (0.57) | (0.70) | (0.92) | (1.08) | (1.35) | (1.02) |
Interest Coverage |
23.12 | 2.69 | 3.36 | 10.00 | (23.23) | 11.45 | 17.67 | 15.51 | 16.69 | 25.15 |
| 50.00% | 0.63% | 0.37% | 13.24% | (165.54%) | (137.79%) | (216.94%) | (194.37%) | (200.12%) | (274.39%) | |
| 8.63% | 0.11% | 0.06% | 1.49% | (7.19%) | 1.74% | 5.67% | 4.63% | 4.62% | 6.05% | |
ROIC |
26.13% | 3.12% | 4.29% | 17.92% | (34.57%) | 16.38% | 45.25% | 43.94% | 71.41% | 66.20% |
Return on Tangible Assets |
139.75% | 2.30% | 1.00% | 45.85% | (117.59%) | (779.02%) | (239.25%) | (144.95%) | (88.96%) | (66.70%) |
Average Days of Receivables |
33.49 | 31.03 | 31.07 | 31.52 | 29.39 | 25.70 | 25.60 | 25.54 | 26.07 | 25.32 |
Research and Development Expense of Revenue |
0.17% | 0.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
3.75% | 3.91% | 3.94% | 3.97% | 3.71% | 3.99% | 2.81% | 2.80% | 2.37% | 2.01% |
Intangible Assets out of Total Assets |
0.23 | 0.25 | 0.22 | 0.20 | 0.19 | 0.18 | 0.20 | 0.18 | 0.15 | 0.19 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.39) | (0.45) | (0.55) | (0.56) | (0.62) | (0.40) | (0.39) | (0.29) | (0.25) | (0.25) |
Graham Number |
164.44 | 15.82 | 8.72 | 58.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
15.89% | 0.16% | 0.07% | 3.84% | (14.63%) | 2.38% | 7.07% | 4.20% | 3.86% | 4.47% |
Free Cash Flow Yield |
12.76% | 12.95% | 14.91% | 15.83% | 12.45% | 8.36% | 9.16% | 5.08% | 6.10% | 5.06% |
Revenue per Share |
898.34 | 1,001.72 | 1,091.79 | 1,279.35 | 1,483.36 | 1,733.20 | 1,961.10 | 2,319.45 | 2,818.30 | 3,264.00 |
Operating CF per Share |
21.47 | 20.89 | 20.56 | 24.22 | 28.28 | 29.11 | 36.56 | 32.39 | 47.76 | 49.80 |
Capex per Share |
(2.54) | (2.79) | (2.84) | (2.80) | (3.99) | (3.51) | (3.95) | (5.16) | (6.74) | (6.03) |
Free Cash Flow per Share |
18.92 | 18.10 | 17.72 | 21.42 | 24.29 | 25.60 | 32.61 | 27.23 | 41.02 | 43.77 |
Cash per Share |
12.59 | 12.85 | 15.19 | 22.23 | 39.09 | 23.19 | 33.15 | 34.41 | 44.67 | 32.16 |
Shareholders Equity per Share |
51.01 | 48.35 | 42.22 | 29.40 | 1.09 | (11.77) | (10.56) | (12.00) | (13.30) | (14.38) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
51.01 | 48.35 | 42.22 | 29.40 | 1.09 | (11.77) | (10.56) | (12.00) | (13.30) | (14.38) |
Free Cash Flow |
4,182.00 | 3,765.00 | 3,479.00 | 3,868.00 | 3,901.00 | 3,899.00 | 4,601.00 | 3,627.00 | 5,226.00 | 5,410.00 |
Working Capital |
1,336.00 | 451.00 | 839.00 | (402.00) | 1,279.00 | (2,235.00) | (3,665.00) | (4,387.00) | (6,206.00) | (9,807.00) |
Capital Expenditures |
(562.00) | (580.00) | (557.00) | (506.00) | (641.00) | (535.00) | (558.00) | (687.00) | (859.00) | (745.00) |
Net Current Asset Value |
(12,748.00) | (13,188.00) | (12,920.00) | (13,716.00) | (19,458.00) | (18,859.00) | (19,518.00) | (21,072.00) | (21,436.00) | (26,890.00) |
EV/EBIT |
5.41 | 45.00 | 31.54 | 11.17 | 0.00 | 27.57 | 13.19 | 20.11 | 20.65 | 18.45 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
4.60 | 38.16 | 26.33 | 9.81 | 0.00 | 22.88 | 11.47 | 18.28 | 19.39 | 17.22 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.52 | 1.29 | 1.19 | 0.45 | 0.44 | 0.36 | 0.28 | 0.27 | 0.25 | 0.27 |
Cash ROIC |
18.50% | 18.27% | 18.44% | 23.15% | 18.00% | 26.28% | 29.86% | 24.63% | 34.26% | 39.16% |
Accounts Receivable Turnover |
10.97 | 11.60 | 11.92 | 12.10 | 12.18 | 13.98 | 14.57 | 15.06 | 15.19 | 15.05 |
Accounts Payable Turnover |
6.28 | 6.24 | 6.14 | 6.17 | 5.94 | 6.51 | 6.56 | 6.61 | 6.75 | 6.75 |
Inventory Turnover |
12.23 | 12.48 | 12.27 | 13.10 | 12.57 | 13.22 | 13.77 | 14.51 | 15.67 | 16.48 |
Average Days of Payables |
60.47 | 59.57 | 61.00 | 61.98 | 62.92 | 55.42 | 58.67 | 58.05 | 58.41 | 56.29 |
Days of Inventory on Hand |
29.78 | 30.19 | 30.11 | 27.89 | 31.07 | 27.21 | 27.19 | 26.06 | 24.28 | 22.72 |
Average Receivables |
18,097.50 | 17,963.00 | 17,978.50 | 19,098.00 | 19,565.50 | 18,882.00 | 18,996.50 | 20,516.00 | 23,632.50 | 26,814.00 |
Average Payables |
29,803.50 | 31,599.50 | 33,015.00 | 35,524.00 | 38,085.00 | 38,530.50 | 40,288.00 | 44,793.50 | 51,213.50 | 57,651.50 |
Average Inventory |
15,306.50 | 15,794.00 | 16,509.50 | 16,721.50 | 17,990.00 | 18,974.00 | 19,196.50 | 20,415.00 | 22,070.00 | 23,604.00 |
Average Assets |
58,746.00 | 60,675.00 | 60,026.50 | 60,459.50 | 63,131.00 | 64,156.50 | 62,809.00 | 64,881.50 | 71,291.50 | 78,731.50 |
Average Common Equity |
10,140.50 | 10,665.00 | 9,172.00 | 6,798.00 | 2,742.00 | (808.50) | (1,641.00) | (1,544.50) | (1,646.50) | (1,735.50) |
Columns are period end dates